Outcome of Cancer Patients Considered for Intensive Care Unit Admission: A Hospital-Wide Prospective Study

This publication has 50 references indexed in Scilit:

• Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
  New England Journal of Medicine, 2003
• Intensified and Shortened Cyclical Chemotherapy for Adult Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology, 2002
• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
  New England Journal of Medicine, 2002
• Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
  The Lancet, 2000
• Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
  Critical Care Medicine, 2000
• Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial
  Journal of Clinical Oncology, 2000
• Changing use of intensive care for hematological patients:
  Intensive Care Medicine, 1999
• Outcomes of Critically Ill Cancer Patients in a University Hospital Setting
  American Journal of Respiratory and Critical Care Medicine, 1999
• Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy
  New England Journal of Medicine, 1998